The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

Pelt, G.W. van; Krol, J.A.; Lips, I.M.; Peters, F.P.; Klaveren, D. van; Boonstra, J.J.; ... ; Slingerland, M. (2020)

Article / Letter to editor

• Esophageal cancer
• Neoadjuvant chemoradiotherapy
• Pathologic response
• Prediction
• Tumor-stroma ratio

• All authors: Pelt, G.W. van; Krol, J.A.; Lips, I.M.; Peters, F.P.; Klaveren, D. van; Boonstra, J.J.; Steur, W.O. de; Tollenaar, R.A.E.M.; Sarasqueta, A.F.; Mesker, W.E.; Slingerland, M.
• Date: 2020-01-31
• Journal: Clinical and Translational Radiation Oncology
• Volume: 20
• Pages: 39 - 44
• DOI: doi:10.1016/j.ctro.2019.11.003
• Link: https://www.sciencedirect.com/science/article/pii/S2405630819301107?via%...